RPB Wasserman Award Aids Research in Diabetic Eye Disease
Dr. Lloyd Paul Aiello
Thursday, July 08, 2010
Lloyd Paul Aiello, M.D., Ph.D., of Joslin and the Department of Ophthalmology at Harvard Medical School has been granted a $60,000 RPB Lew R. Wasserman Merit Award by Research to Prevent Blindness.
Established in 1995, the RPB Lew R. Wasserman Merit Awards provide unrestricted support to mid-career M.D. and Ph.D. scientists who hold primary positions within departments of ophthalmology and who are actively engaged in eye research at medical institutions in the United States.
“As a clinical ophthalmologist, retina specialist, and doctorally trained biochemist, Dr. Aiello has worked over the past two decades to expand our understanding of the basic molecular mechanisms underlying retinal vascular disease, especially with regard to the role of growth factors in diabetic retinopathy and diabetic macular edema,” commented Joan W. Miller, M.D., Chair of the Harvard Medical School Department of Ophthalmology.
“He is one of our most innovative and thoughtful clinician scientists," added Dr. Miller. "I have no doubt that the Wasserman Award will contribute toward our further understanding of retinal disease and allow Dr. Aiello to develop new and better treatments for diabetic retinopathy.”
“I’m highly honored to receive the Wasserman Award, which will help us address the problem of vision loss among people with diabetes,” said Dr. Aiello. “Studies funded by the Award will allow us to determine the complete set of proteins found in the liquid parts of the eye in patients with diabetes. We then can analyze the proteins associated with patients who respond well to current vision therapies versus the proteins associated with patients who don’t. This information may yield insights that let us provide better treatments.”
RPB is the world’s leading voluntary organization supporting eye research. Since it was founded in 1960, RPB has channeled hundreds of millions of dollars to medical institutions throughout the United States for research into all blinding eye diseases.
News | Diabetes Research
News from Joslin
Page last updated: May 25, 2016